Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

Published:2009-12 Issue:12 Volume:8 Page:1103-1110
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Micallef Joëlle,Attarian Shahram,Dubourg Odile,Gonnaud Pierre-Marie,Hogrel Jean-Yves,Stojkovic Tanya,Bernard Rafaelle,Jouve Elisabeth,Pitel Severine,Vacherot Francois,Remec Jean-Francois,Jomir Laurent,Azabou Eric,Al-Moussawi Mahmoud,Lefebvre Marie-Noelle,Attolini Laurence,Yaici Sadek,Tanesse Daniel,Fontes Michel,Pouget Jean,Blin Olivier

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference37 articles.

1. Genetic and clinical aspects of Charcot–Marie–Tooth's disease;Skre;Clin Genet,1974

2. Estimation of the mutation frequencies in Charcot–Marie–Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study;Nelis;Eur J Hum Genet,1996

3. Charcot–Marie–Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation;Boerkoel;Ann Neurol,2002

4. DNA duplication associated with Charcot–Marie–Tooth disease type 1A;Lupski;Cell,1991

5. Duplication in chromosome 17p11.2 in Charcot–Marie–Tooth neuropathy type 1a (CMT1a). The HMSN Collaborative Research Group;Raeymaekers;Neuromuscul Disord,1991

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1/2a, open label study to evaluate the safety and efficacy of a plasmid DNA encoding human hepatocyte growth factor in patients with Charcot-Marie-Tooth disease 1A;2024-06-14

2. Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature review of their measurement properties;European Journal of Physical and Rehabilitation Medicine;2024-04

3. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure;Neurology;2024-02-13

4. Peripheral Neuropathy and Decreased Locomotion of a RAB40B Mutation in Human and Model Animals;Experimental Neurobiology;2023-12-31

5. Proteostasis plays an important role in demyelinating Charcot Marie Tooth disease;Biochemical Pharmacology;2023-10